Regeneron Pharmaceuticals (REGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2009 | 06-2009 | 03-2009 | 12-2008 | 09-2008 | |
| Sales | 117,455 | 90,032 | 74,981 | 55,837 | 65,584 |
| Cost of Goods | 472 | 435 | 392 | 631 | 292 |
| Gross Profit | 116,983 | 89,597 | 74,589 | 55,206 | 65,292 |
| Operating Expenses | 118,746 | 106,298 | 92,119 | 88,656 | 83,484 |
| Operating Income | -1,291 | -16,266 | -17,138 | -32,819 | -17,900 |
| Interest Expense | 581 | 0 | 0 | 295 | 1,772 |
| Other Income | 857 | 1,328 | 1,750 | 2,648 | 3,667 |
| Pre-tax Income | -1,015 | -14,938 | -15,388 | -30,466 | -16,005 |
| Income Tax | N/A | N/A | N/A | -728 | 3,079 |
| Net Income Continuous | -1,015 | -14,938 | -15,388 | -29,738 | -19,084 |
| Net Income | $-1,015 | $-14,938 | $-15,388 | $-29,738 | $-19,084 |
| EPS Basic Total Ops | -0.01 | -0.19 | -0.19 | -0.37 | -0.24 |
| EPS Basic Continuous Ops | -0.01 | -0.19 | -0.19 | -0.38 | -0.24 |
| EPS Diluted Total Ops | -0.01 | -0.19 | -0.19 | -0.37 | -0.24 |
| EPS Diluted Continuous Ops | -0.01 | -0.19 | -0.19 | -0.38 | -0.24 |
| EBITDA(a) | $2,299 | $-13,268 | $-14,414 | $-30,193 | $-15,126 |